Showing results (21-30 of 116) with videos related to
Sort By:
Pageof 12
The American Journal of the Medical Sciences|January 7, 2010
Delayed hemolytic transfusion reaction in sickle cell diseaseLeslie P Scheunemann, Kenneth I AtagaHematology. American Society of Hematology. Education Program|February 20, 2015
Does hydroxyurea prevent pulmonary complications of sickle cell disease?Tyler W Buckner, Kenneth I AtagaCurrent Molecular Medicine|November 11, 2008
Hypercoagulability in sickle cell disease and beta-thalassemiaSylvia T Singer, Kenneth I AtagaHematology. American Society of Hematology. Education Program|November 21, 2007
Hypercoagulability in sickle cell disease: new approaches to an old problemKenneth I Ataga, Nigel S KeyHematology. American Society of Hematology. Education Program|February 20, 2015
Pulmonary hypertension in sickle cell disease: diagnosis and managementKenneth I Ataga, Elizabeth S KlingsExpert Opinion on Pharmacotherapy|March 29, 2013
The acute chest syndrome of sickle cell diseasePayal C Desai, Kenneth I AtagaExpert Opinion on Orphan Drugs|March 16, 2019
Advances in new drug therapies for the management of sickle cell diseaseKenneth I Ataga, Payal C DesaiBlood|January 15, 2008
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemiaKenneth I Ataga, Wally R Smith, Laura M De Castro, et al.Hematology/Oncology Clinics of North America|November 18, 2022
The Evolving Landscape of Drug Therapies for Sickle Cell DiseaseParul Rai, Payal C Desai, Kenneth I AtagaBlood Reviews|January 19, 2016
Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapiesDenis Noubouossie, Nigel S Key, Kenneth I AtagaPageof 12